nba all star game
Photos: Violence in Sambhal over Mosque surveyFormer Blue Jays outfielder Rico Carty dies at 85
None
That Maharashtra’s politics was headed for a structural break became clear on October 25, 2019, when the undivided Shiv Sena stalled the then National Democratic Alliance’s (NDA) government formation despite the alliance winning a clear majority (161 out of 288 ACs) in the assembly elections. When the Shiv Sena decided to join hands with its ideological and political rivals, the Congress and the Nationalist Congress Party (NCP), to form a government in Maharashtra on November 28, 2019, a political realignment of fortunes became preordained. The only question was whether the combined strength of the Congress and the two regional parties would destroy the Bharatiya Janata Party (BJP) in the state? Also Read | Maharashtra polls: Independents finish second in 19 constituencies It has taken five years for that question to be answered –– that local body polls were not conducted in the interim kept it in abeyance – but it seems to have become clear now. The BJP has turned the tables and now it looks like the Congress is left without any worthy allies in the state with the BJP-aligned factions of the Shiv Sena and the NCP registering big victories in the elections. The BJP-led NDA, which is now called Mahayuti, has returned with a much bigger (235 out of 288) majority in Maharashtra now. And the BJP itself would appear to be stronger than before. The political and geographical mechanics of this tectonic shift are worth looking at in detail. Let us look at the geographical change first In the 2019 assembly elections, the Congress and the BJP won a total of 149 ACs (BJP 105 and Congress 44) in Maharashtra. The BJP has won 98 of the 105 ACs it won in 2019 once again this time. Of the seven it did not win in 2024 but won in 2019, it did not contest one and gave it to its allies to fight. The remaining six have been won by the Congress or its allies. If one were to compare an NDA (BJP+Shiv Sena) to NDA (BJP+Shiv Sena+NCP) comparison between the 2019 and 2024 assembly elections, the alliance has retained a massive 87% of the 161 ACs it won in 2019 and gained another 95 ACs. NDA lost just 20 of the ACs it won in 2019 in these elections. There are 35 ACs which have been won by the Mahayuti in the 2024 elections which were never won by the BJP or any of its allies since 2009. This includes ACs won by the Shiv Sena in 2014 when Congress, BJP, NCP and Shiv Sena contested separately. A pre-2009 comparison is not possible because of a change in AC boundaries in the 2008 delimitation. Things are on the other extreme for the Congress-led Maharashtra Vikas Agadi (MVA). Of the 98 ACs the Congress-NCP alliance won in 2019, it has retained just 24 and lost 71 of them to the Mahayuti. To be sure, the MVA has won 26 ACs that the Congress-NCP alliance did not win in 2019. A large number of them (17) are because of the Shiv Sena (UBT). However, the number is insignificant in the larger scheme of things. The new assembly might not even have a leader of opposition. What explains this change in Maharashtra’s political map? This is where it becomes interesting. The political contest in Maharashtra in these elections was an eclectic mix of ideology and a battle for political inheritance. The first was in the contest between the BJP and the Congress-led alliances and two factions of the Shiv Sena and NCP. The second was within the Shiv Sena and the NCP in terms of claiming the legacy of the undivided parties. Voters seem to have decided both clearly. Also Read | ‘Everyone knows who is NCP founder’: Sharad Pawar on nephew Ajit after Maharashtra election results There were 73 head-to-head contests between the Congress-BJP in these elections. the BJP has won 86.3% of these, a big improvement from its 68.4% strike rate in similar contests in the 2019 assembly elections. The BJP has also done extremely well in contests against non-Congress MVA components with a strike rate of 87.2%. Congress’s strike rate against non-BJP Mahayuti is just 18.5%, only marginally higher than its performance against the BJP. Chart 1: The Shiv Sena (UBT) and Shiv Sena fought 53 head-to-head contests. Shiv Sena has won 69.9% of these contests. Almost a similar outcome can be seen in the contests between the NCP (Sharad Pawar) or NCP(SP) and the NCP, with the latter winning 70.7% of the 41 head-to-head contests. Chart 2: There is also another way to look at the political realignment in Maharashtra. The MLA count of the BJP and the combined count of the Shiv Sena and NCP has increased or almost remained the same in 2024 compared to 2019. The Shiv Sena had 56 MLAs in 2019 and the Shiv Sena and Shiv Sena (UBT) have won 57 and 20 MLAs in these elections. The NCP had 54 MLAs in 2019 and the NCP and NCP (SP) factions have won 41 and 10 ACs in these elections. The only party which has seen its MLA count fall drastically is the Congress which will have to contend with just 16 MLAs compared to 44 in 2019. The Shiv Sena and the NCP might have seen palace coups in the period between 2019 and 2024, but it is the Congress in Maharashtra that is facing a battle for survival now.BY MELISSA GOLDIN Social media users are misrepresenting a report released Thursday by the Justice Department inspector general’s office, falsely claiming that it’s proof the FBI orchestrated the Capitol riot on Jan. 6, 2021. Related Articles Nation | Drones, planes or UFOs? Americans abuzz over mysterious New Jersey sightings Nation | OpenAI whistleblower found dead in San Francisco apartment Nation | Judge rejects an attempt by Trump campaign lawyer to invalidate guilty plea in Georgia election case Nation | Texas’ abortion pill lawsuit against New York doctor marks new challenge to interstate telemedicine Nation | US military flies American released from Syrian prison to Jordan, officials say The watchdog report examined a number of areas, including whether major intelligence failures preceded the riot and whether the FBI in some way provoked the violence. Claims spreading online focus on the report’s finding that 26 FBI informants were in Washington for election-related protests on Jan. 6, including three who had been tasked with traveling to the city to report on others who were potentially planning to attend the events. Although 17 of those informants either entered the Capitol or a restricted area around the building during the riot, none of the 26 total informants were authorized to do so by the bureau, according to the report. Nor were they authorized to otherwise break the law or encourage others to do so. Here’s a closer look at the facts. CLAIM: A December 2024 report released by the Department of Justice’s Office of the Inspector General is proof that the Jan. 6 Capitol riot was a setup by the FBI. THE FACTS: That’s false. The report found that no undercover FBI employees were at the riot on Jan. 6 and that none of the bureau’s informants were authorized to participate. Informants, also known as confidential human sources, work with the FBI to provide information, but are not on the bureau’s payroll. Undercover agents are employed by the FBI. According to the report, 26 informants were in Washington on Jan. 6 in connection with the day’s events. FBI field offices only informed the Washington Field Office or FBI headquarters of five informants that were to be in the field on Jan. 6. Of the total 26 informants, four entered the Capitol during the riot and an additional 13 entered a restricted area around the Capitol. But none were authorized to do so by the FBI, nor were they given permission to break other laws or encourage others to do the same. The remaining nine informants did not engage in any illegal activities. None of the 17 informants who entered the Capitol or surrounding restricted area have been prosecuted, the report says. A footnote states that after reviewing a draft of the report, the U.S. attorney’s office in Washington said that it “generally has not charged those individuals whose only crime on January 6, 2021 was to enter restricted grounds surrounding the Capitol, which has resulted in the Office declining to charge hundreds of individuals; and we have treated the CHSs consistent with this approach.” The assistant special agent in charge of the Washington Field Office’s counterterrorism division told the inspector general’s office that he “denied a request from an FBI office to have an undercover employee engage in investigative activity on January 6.” He, along with then-Washington Field Office Assistant Director in Charge Steven D’Antuono, said that FBI policy prohibits undercover employees at First Amendment-protected events without investigative authority. Many social media users drew false conclusions from the report’s findings. “JANUARY 6th WAS A SETUP!” reads one X post that had received more than 11,400 likes and shares as of Friday. “New inspector general report shows that 26 FBI/DOJ confidential sources were in the crowd on January 6th, and some of them went into the Capitol and restricted areas. Is it a coincidence that Wray put in his resignation notice yesterday? TREASON!” The mention of Wray’s resignation refers to FBI Director Christopher Wray’s announcement Wednesday that he plans to resign at the end of President Joe Biden’s term in January. Other users highlighted the fact that there were 26 FBI informants in Washington on Jan. 6, but omitted key information about the findings of the report. These claims echo a fringe conspiracy theory advanced by some Republicans in Congress that the FBI played a role in instigating the events of Jan. 6, 2021, when rioters determined to overturn Republican Donald Trump’s 2020 election loss to Democrat Joe Biden stormed the Capitol in a violent clash with police. The report knocks that theory down. Wray called such theories “ludicrous” at a congressional hearing last year. Asked for comment on the false claims spreading online, Stephanie Logan, a spokesperson for the inspector general’s office, pointed The Associated Press to a press release about the report. In addition to its findings about the the FBI’s involvement on Jan. 6, the report said that the FBI, in an action its now-deputy director described as a “basic step that was missed,” failed to canvass informants across all 56 of its field offices for any relevant intelligence ahead of time. That was a step, the report concluded, “that could have helped the FBI and its law enforcement partners with their preparations in advance of January 6.” However, it did credit the bureau for preparing for the possibility of violence and for trying to identify known “domestic terrorism subjects” who planned to come to Washington that day. The FBI said in a letter responding to the report that it accepts the inspection general’s recommendation “regarding potential process improvements for future events.”
Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth
Sen. Duckworth says Trump defense secretary pick is "flat-out wrong" about women in combat rolesTrump isn't back in office but he's already pushing his agenda and negotiating with world leadersMaresca led the Foxes to the Sky Bet Championship title last season before joining Chelsea over the summer. Leicester famously toasted their improbable Premier League success in 2016 with an impromptu bash at Vardy’s house. But the venue for last April’s party was not at the striker’s abode, but at Maresca’s house when the players turned up unannounced at 2am. Maresca recalled: “The best present I had from last season was when we got promoted and they arrived at my home. All the team. “This showed the connection between the players; they could go for a party at a different place but they all arrived at my home. It was a fantastic connection and I will always be thankful for them. “I was at home celebrating with my staff and my family and about two o’clock in the morning all the squad was there. We celebrated all together. “When I was a player and I won things I never thought to go to the manager’s home. That shows the connection.” Similarly to when they clinched the Premier League crown, Leicester were not actually playing when they found out they were promoted after Leeds lost at QPR. “To be honest I was at home watching the game and when it finished all the staff came over – and later the players,” added the Italian. “They didn’t knock on the door, they were in the garden and knocked on the window. What time did they leave? I don’t remember.” Vardy might not be having a party at the end of this season but he is still banging in the goals at 37 and Maresca rates the striker even more highly than England’s two top goalscorers – Harry Kane and Wayne Rooney. “People don’t realise how good he is,” added Maresca. “I know England have been quite lucky because of Kane and Rooney, this type of striker, they are fantastic. “But Jamie is, if you ask me, the best one.” Maresca returns to the King Power Stadium for the first time with Chelsea on Saturday, but he will be without captain Reece James due to a hamstring problem.
Bucs topple giantsIn a steady session on Friday, U.S. stocks rounded off the week near unchanged marks despite Broadcom's AI chip optimism boosting its shares and market cap past $1 trillion. The Nasdaq advanced for the fourth consecutive week, as tech stocks continued their ascent. Meanwhile, yields on U.S. Treasuries rose, spotlighting investors' focus on interest rates. Anticipation builds for a Federal Reserve rate cut, motivated by an in-line inflation report. Yet, the stock markets took a breather, reflecting investor sentiment swayed by potential profitability shifts under Donald Trump's incoming administration. (With inputs from agencies.)
AP Sports SummaryBrief at 1:56 p.m. ESTCombination brings emerging leader in Italian natural gas and renewable natural gas to public markets Shares of AleAnna, Inc. to begin trading on Nasdaq on December 16 under the ticker symbol “ANNA” AleAnna stands on the cusp of a major milestone, with the first phase of natural gas production from the Longanesi Field projected to commence in Q1 2025 DALLAS and VANCOUVER, British Columbia and ROME, Dec. 13, 2024 (GLOBE NEWSWIRE) -- AleAnna, Inc. (together with its subsidiaries, “AleAnna” or the “Company”), an emerging leader in Italy’s energy landscape, announced the completion of the previously announced business combination (the “Business Combination”) between Swiftmerge Acquisition Corp. (NASDAQ: IVCP) (“Swiftmerge”), a special purpose acquisition company, and AleAnna Energy, LLC (“AleAnna Energy”). Concurrent with the completion of the Business Combination, Swiftmerge has changed its name to AleAnna, Inc. Commencing at the open of trading on December 16, 2024, the Class A shares of common stock and warrants of AleAnna are expected to begin trading on the NASDAQ Capital Market under the ticker symbols “ANNA” and “ANNAW”, respectively. The transaction was unanimously approved by the Board of Directors of Swiftmerge and was approved at an extraordinary general meeting (the “Shareholders Meeting”) of Swiftmerge’s shareholders on December 12, 2024. Former equity holders of AleAnna Energy rolled 100% of their equity interests into the combined company. Prior to the execution of the Agreement and Plan of Merger, dated June 6, 2024, AleAnna Energy's equity holders contributed over $60 million in cash, bringing the company's total cumulative investment to nearly $175 million. This infusion of capital enabled the completion of the Longanesi Field tie-in and the acquisition of initial renewable natural gas (“RNG”) assets, both finalized in Q3 2024. Additionally, the investment covered expenses related to the business combination and provided funding for general corporate liquidity. As of the transaction close, AleAnna had approximately $28 million in cash and cash equivalents on its balance sheet and no debt. This disciplined approach to financial management has empowered AleAnna to allocate significant capital to innovative exploration and development projects while preserving financial flexibility. Long History In Developing Resources in Italy AleAnna has a distinguished history in Italy, having been a leader in energy exploration and development for over a decade. Since its founding in 2007, the company has been dedicated to unlocking the significant potential of Italy’s natural gas reserves through the application of cutting-edge seismic imaging and environmentally responsible practices. AleAnna holds one of the largest portfolios of exploration permits and production concessions in Italy, spanning over 2.3 million acres. By combining advanced technology with a deep respect for Italy’s cultural and environmental heritage, AleAnna is expected to play a pivotal role in bolstering the nation’s energy independence and economic growth, earning its reputation as a trusted partner in Italy’s energy future. Positioning itself as a leader in both onshore conventional natural gas and renewable natural gas (RNG) production, AleAnna is at the forefront of building a secure and reliable domestic energy supply for Italy and the broader European market. The company stands on the cusp of a major milestone, with the first phase of natural gas production from the Longanesi Field projected to commence in Q1 2025. Alongside this, additional gas discoveries at Gradizza and Trava, 13 development prospects in various permitting stages, and leases covering approximately 2.3 million net acres underscore AleAnna’s commitment to future exploration and development. AleAnna is also helping drive the European Union's clean energy transition through its innovative approach to RNG. Leveraging the strategic overlap between its conventional and renewable assets in the Po Valley, AleAnna is transforming agricultural waste into renewable energy. With three RNG facilities operational and over 100 additional opportunities identified, AleAnna is poised for significant expansion in this sector. Guided by a commitment to corporate responsibility and a vision for a sustainable future, AleAnna integrates conventional and renewable energy solutions to reduce Europe’s carbon footprint and advance its clean energy objectives. By delivering innovative energy solutions, AleAnna continues to shape Italy’s energy landscape and support the EU’s transition toward a greener future. Experienced Management And Board Of Directors The combined company will be led by William Dirks as Executive Director and Marco Brun as Chief Executive Officer, supported by a seasoned and highly skilled executive team. AleAnna’s leadership team brings extensive expertise gained from top-tier energy companies, including Shell, Eni, and Exxon. This seasoned group combines in-depth knowledge of energy technology, operations, and business development with well-established regulatory and industry networks in Italy. Their collective experience equips AleAnna to effectively navigate the dynamic and rapidly evolving energy landscape. The Board of Directors, which will include Graham van’t Hoff, William Dirks, Marco Brun, Duncan Palmer, and Curtis Hébert, collectively brings a wealth of experience spanning global energy markets, technical and operational expertise, European energy development, financial management, governance, and regulatory policy. This diverse set of skills and perspectives ensures comprehensive strategic oversight and positions AleAnna for sustained growth and success. With over 15 years of investment and operational experience in Italy, AleAnna has a competitive advantage in securing critical permits and approvals, positioning it ahead of its peers. The company’s approach integrates cutting-edge technologies and industry-leading practices with strategic capital allocation to maximize the value of its conventional and renewable natural gas (RNG) assets. AleAnna is dedicated to sustainable, low-cost growth while maintaining strict capital discipline. By prioritizing innovation, efficiency, and long-term shareholder value, AleAnna is well-positioned to lead the next phase of Italy’s energy transformation. Management Commentary Bill Dirks, Executive Director of AleAnna, commented, “Our investment in state-of-the-art subsurface technology has been a game-changer for AleAnna. By leveraging advanced seismic imaging and cutting-edge data analysis, we have achieved unparalleled accuracy in identifying and developing Italy’s natural gas resources. This technology not only enhances our operational efficiency but also ensures that our exploration and development activities are conducted in an environmentally responsible manner, aligning with our commitment to sustainability and innovation in the energy sector.” Marco Brun, AleAnna’s Chief Executive Officer, added, “We stand at a pivotal moment in AleAnna's journey. As we gear up for production at Longanesi and scale our renewable natural gas (RNG) operations, we are proud to be at the forefront of driving a sustainable energy future. This strategy not only delivers value to AleAnna shareholders but also plays a key role in reshaping the energy landscape for generations to come.” About AleAnna, Inc. AleAnna is an innovative energy company dedicated to unlocking Italy's extensive natural gas reserves and advancing renewable energy solutions to address the country's energy needs and support Europe's sustainability and energy security goals. With a vast portfolio encompassing over 2.3 million acres of potential resources and state-of-the-art technologies, AleAnna is poised to lead Italy's energy transition. Guided by a commitment to environmental responsibility and operational excellence, AleAnna is shaping a sustainable and secure energy future. The company operates regional headquarters in Dallas, TX, and Rome, Italy, serving as strategic hubs for its global and local initiatives. Forward-Looking Statements The information included herein contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Certain statements, other than statements of present or historical fact included herein, regarding the Business Combination, the anticipated benefits of the Business Combination, AleAnna’s future financial performance following the Business Combination, as well as AleAnna’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used herein, including any statements made in connection herewith, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar expressions are intended to identify forward-looking statements. However, not all forward-looking statements contain such identifying words. These forward-looking statements are based on AleAnna management’s current expectations and assumptions about future events. They are based on current information about the outcome and timing of future events. You should not place undue reliance upon any forward-looking statements, which speak only as of the date made. Except as otherwise required by applicable law, AleAnna disclaims any duty to update any forward-looking statements, all expressly qualified by the statements in this section, to reflect events or circumstances after the date hereof. AleAnna cautions you that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of AleAnna. These risks include, but are not limited to, general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the ability to recognize the anticipated benefits of the Business Combination and any transactions contemplated thereby, which may be affected by, among other things, competition, the ability of AleAnna to grow and manage growth profitably and retain its management and key employees; AleAnna’s need for additional capital to execute its business plan and support its anticipated growth; costs related to the Business Combination; the risks associated with the growth of AleAnna’s business and the timing of expected business milestones; AleAnna’s ability to identify, develop and operate new projects; the reduction or elimination of government economic incentives to the natural gas market; delays in acquisition, financing, construction and development of new projects; decline in public acceptance and support of renewable energy development and projects; the ability to obtain necessary regulatory and governmental permits and approvals; uncertainty regarding the EU’s clean energy transition, including existing regulations and changes to regulations and policies that affect AleAnna’s operations; the ability to maintain the listing of AleAnna’s securities on a national securities exchange; and the effects of competition on AleAnna’s future business. These forward-looking statements involve significant risks and uncertainties, and should one or more of the risks or uncertainties described herein and in any statements made in connection in addition to these occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. There may be additional risks that AleAnna does not know or that AleAnna currently believes are immaterial that could cause actual results to differ from those contained in the forward-looking statements. Additional information concerning these and other factors that may impact AleAnna’s expectations and projections can be found in filings it makes with the SEC, including the definitive proxy statement/prospectus filed by Swiftmerge and AleAnna Energy with the SEC on November 21, 2024, including those under “Risk Factors” therein, and other documents filed or to be filed with the SEC by AleAnna. SEC filings are available on the SEC’s website at www.sec.gov . Investor Relations Contact For AleAnna, Inc.: Bill Dirks wkdirks@aleannagroup.comDefending national champion South Carolina women defeated by UCLA 77-62 for their first loss since the 2023 Final Four
Key Leadership Appointments Bring New Skills and Capabilities to Organization EMERYVILLE, Calif. , Dec. 13, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced the recent appointments of Dan Maziasz as Chief Business Officer, Cara Bauer as Chief Human Resources Officer, and Tracy Rossin as Senior Vice President of Corporate Affairs, Communications and Investor Relations. "I'm pleased to welcome three industry leaders to our Kyverna team," said Warner Biddle , Chief Executive Officer of Kyverna. "Dan, Cara and Tracy bring important new skills and capabilities to Kyverna as we continue to support the company's next phase of growth and work to bring a transformative change to patients living with severe autoimmune diseases." Mr. Maziasz brings over 25 years of leadership and business experience across several leading biotechnology and large pharmaceutical companies. Mr. Maziasz most recently served as Chief Business Officer at Atara Biotherapeutics, the first company in the world to receive regulatory approval of an allogeneic T-cell immunotherapy. At Atara, Mr. Maziasz led various corporate initiatives including strategic planning, licensing transactions with industry partners, and research collaborations with academic groups. Before his time at Atara, Mr. Maziasz was Vice President, Corporate Strategy and Business Development at Kite Pharma, a global cell therapy leader, prior to its acquisition by Gilead Sciences. Mr. Maziasz also spent more than a decade at Amgen, where he held roles of increasing responsibility in the US, Europe , and Asia across business development, corporate strategy, finance, and commercial functions. Ms. Bauer brings more than 25 years of experience in global human resources leadership to Kyverna, having served most recently as Global Head of Human Resources at Kite, a Gilead Company, where she oversaw all HR strategy and operations during a period of hypergrowth and global expansion which strengthened the company's leadership position in cell therapy. Prior to this role, she served as the Global Head of HR for the Entertainment Division at Riot Games where she worked directly with the founders to build an Entertainment Studio separate from the core gaming business. Ms. Bauer has also held various HR leadership roles at companies such as Netflix, Amgen, Gartner and Novo Nordisk. Ms. Rossin brings more than 20 years of strategic communications experience to Kyverna, having most recently served as the Head of Public Affairs at Kite, where she was responsible for leading corporate, product and employee communications in addition to patient advocacy. Prior to this role, she served as Vice President, Global Head of Communications at Innate Pharma, an oncology-focused biotech company, where she led both corporate and financial communications. Ms. Rossin also spent more than 12 years at AstraZeneca/MedImmune, where she held multiple U.S. and global communications roles for key therapeutic areas across AstraZeneca's portfolio before serving as the Head of Corporate Affairs at MedImmune, the global biologics research and development arm of AstraZeneca. Before joining AstraZeneca, she held various positions at global public relations agencies working with corporate and healthcare related clients. Inducement Grant In connection with the appointment of Mr. Maziasz as Kyverna's Chief Business Officer, on December 9, 2024 , Kyverna granted Mr. Maziasz an option to purchase 350,000 shares of its common stock (Option). The Option was granted pursuant to the Kyverna Therapeutics, Inc. 2024 Inducement Equity Incentive Plan, as approved by the Compensation Committee of Kyverna's Board of Directors on September 14, 2024 , and was granted as an inducement material to Mr. Maziasz's employment with Kyverna in accordance with Nasdaq Listing Rule 5635(c)(4). The exercise price of the Option was $4.86 , the closing price of Kyverna's common stock on December 9, 2024 , the date of grant. The Option will vest over four years, with 25% of the total number of shares subject to the Option vesting on the one-year anniversary of Mr. Maziasz's appointment and 1/48th of the total number of shares subject to the Option vesting monthly thereafter, subject in each case to Mr. Maziasz's continued service to Kyverna on each vesting date. Kyverna is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4). About Kyverna Therapeutics Kyverna Therapeutics, Inc. (Nasdaq: KYTX) is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead CAR T-cell therapy candidate, KYV-101 is advancing through clinical development with sponsored clinical trials across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center Phase 1/2 trials in the United States and Germany for patients with lupus nephritis. Kyverna's pipeline includes next-generation CAR T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases. For more information, please visit https://kyvernatx.com . Forward-Looking Statements Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." The words, without limitation, "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Forward-looking statements in this press release include, without limitation, those related to: the potential impact of the clinical outcomes from the ongoing clinical programs; the potential impact of the new data on the treatment efficacy and safety profile of KYV-101; the potential that the results of the ongoing trials could drastically change the treatment landscape for the targeted autoimmune diseases; Kyverna's goals to develop certain paradigm-shifting treatment options; the potential for KYV-101 to provide durable, immunosuppressant-free remission for autoimmune disease patients; Kyverna's beliefs about the differentiated properties of KYV-101; and Kyverna's clinical trials, investigator-initiated trials and named-patient activities. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of Kyverna's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that Kyverna has filed or may subsequently file with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release are based on the current expectations of Kyverna's management team and speak only as of the date hereof, and Kyverna specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Contact: Investors: InvestorRelations@kyvernatx.com Media: media@kyvernatx.com View original content to download multimedia: https://www.prnewswire.com/news-releases/kyverna-therapeutics-strengthens-leadership-team-to-accelerate-next-phase-of-growth-302331659.html SOURCE Kyverna Therapeutics